ES258463A1 - Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis - Google Patents

Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis

Info

Publication number
ES258463A1
ES258463A1 ES0258463A ES258463A ES258463A1 ES 258463 A1 ES258463 A1 ES 258463A1 ES 0258463 A ES0258463 A ES 0258463A ES 258463 A ES258463 A ES 258463A ES 258463 A1 ES258463 A1 ES 258463A1
Authority
ES
Spain
Prior art keywords
type
avirulent
virus
poliomyelitis
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0258463A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES258463A1 publication Critical patent/ES258463A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un procedimiento de preparar una vacuna trivalente viva contra la poliomielitis adecuada para administración oral cuando está en forma de dosis unitaria, caracterizada por mezclar virus atenuado de poliomielitis Tipo I avirulento para seres humanos, virus atenuado de poliomielitis Tipo III avirulento para seres humanos, virus atenuado de poliomielitis Tipo II que tiene adaptación en embrión de pollo y avirulento para seres humanos, y que no inhibe la infección por virus avirulentos Tipo I y Tipo III, y formar unidades de dosificación a partir de la mezcla resultante conteniendo cada una por lo menos log 6 de cada tipo de virus.
ES0258463A 1959-06-22 1960-05-30 Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis Expired ES258463A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US821720A US2966443A (en) 1959-06-22 1959-06-22 Trivalent poliomyelitis live virus vaccine

Publications (1)

Publication Number Publication Date
ES258463A1 true ES258463A1 (es) 1960-11-16

Family

ID=25234127

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0258463A Expired ES258463A1 (es) 1959-06-22 1960-05-30 Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis

Country Status (5)

Country Link
US (1) US2966443A (es)
BE (1) BE591268A (es)
ES (1) ES258463A1 (es)
FR (1) FR668M (es)
LU (1) LU38816A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147185A (en) * 1959-09-10 1964-09-01 Merck & Co Inc Process for purifying viral substances and composition
GB896439A (en) * 1959-12-28 1962-05-16 Glaxo Lab Ltd Cellulose derivatives useful as anion-exchange materials and their application
US3244590A (en) * 1960-12-23 1966-04-05 Rutgers Res And Educational Fo Polyenic compounds and procedures related thereto
DE1157734B (de) * 1961-08-16 1963-11-21 Behringwerke Ag Verfahren zur Herstellung von haltbaren, oral zu verabreichenden Poliomyelitisvirus-Praeparaten
US3143473A (en) * 1961-08-16 1964-08-04 Behringwerke Ag Stable, solid, oral live antipoliomyelitis vaccine compositions and process for preparing them
US3128229A (en) * 1961-10-05 1964-04-07 Baylor Medical Foundation Stabilization of viral vaccine and inactivation of adventitious tissue culture contaminants therein
GB1015251A (en) * 1963-03-12 1965-12-31 Glaxo Lab Ltd Aqueous pharmaceutical compositions in capsule form
GB1171125A (en) * 1966-06-08 1969-11-19 Glaxo Lab Ltd Improvements in or relating to Injectable Preparations
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination

Also Published As

Publication number Publication date
LU38816A1 (es) 1960-08-16
US2966443A (en) 1960-12-27
BE591268A (fr) 1960-11-28
FR668M (es) 1961-07-10

Similar Documents

Publication Publication Date Title
ES258463A1 (es) Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis
ES394860A1 (es) Procedimiento para la produccion de una vacuna viva contra la bursitis infecciosa de las gallinas.
ES290512A1 (es) Procedimiento para la estabilización de materiales labiles de virus antígenos
ES294897A1 (es) Mejoras introducidas en la preparación de composiciones farmacéuticas en forma de dosis unitarias
ES306989A1 (es) Procedimiento para la produccion de una composicion de vacuna veterinaria.
ES287586A1 (es) Un procedimiento para la preparación de una composición terapéutica
ES306377A1 (es) Procedimiento para la preparacion de una composicion penetrante por las membranas.
GR21931B (el) Μεθοδος δια την παρασκευην τρισθενους ζωντος εμβολιου πολιομυελιτιδος.
ES311990A1 (es) Procedimiento para la preparacion de vacunas contra la gripe
ES273008A1 (es) Procedimiento para la obtencion de preparacion de virus de poliomielitis duraderos y administrables por via bucal
ES281617A1 (es) Un procedimiento para la fabricación de una composición terapéutica
FI40401C (fi) Menetelmä kestävien, suun kautta nautittavien poliomyelitisvirus-preparaattien valmistamiseksi
ES241605A1 (es) MEJORAS INTRODUCIDAS EN LA PREPARACIoN DE COMPUESTOS ANESTÉSICOS
BE585993A (fr) Compositions therapeutiques comprenant un vaccin de bacterie, de ricketsie ou de virus, ainsi que leur préparation.
CA636550A (en) Trivalent poliomyelitis live virus vaccine
CA607992A (en) Stable poliomyelitis live virus vaccine
ES348634A1 (es) Mejoras introducidas en un procedimiento para preparar com-posiciones insecticidas.
ES301232A1 (es) Procedimiento para la obtencion de una vacuna contra la glosopeda
ES289869A1 (es) Metodo para esterilizar composiciones acuosas
ES246350A1 (es) Mejoras introducidas en la preparacion de composiciones para el tratamiento esterno de animales
ES71929U (es) Extractor de humos perfeccionado
ES279927A1 (es) Procedimiento de preparaciën de una vacuna contra la fiebre aftosa
Torkelson The effects of X-rays on the morphology and histology of early chick development
JPS51125753A (en) An injection for treating fish vitaminosis
ES279551A1 (es) Procedimiento para la fabricación de una composición terapéutica